Diego J. Laderach

1.7k total citations
29 papers, 1.4k citations indexed

About

Diego J. Laderach is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Diego J. Laderach has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 16 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Diego J. Laderach's work include Galectins and Cancer Biology (17 papers), Signaling Pathways in Disease (9 papers) and Glycosylation and Glycoproteins Research (7 papers). Diego J. Laderach is often cited by papers focused on Galectins and Cancer Biology (17 papers), Signaling Pathways in Disease (9 papers) and Glycosylation and Glycoproteins Research (7 papers). Diego J. Laderach collaborates with scholars based in Argentina, France and United States. Diego J. Laderach's co-authors include Daniel Compagno, Anne Galy, Lucas D. Gentilini, Gabriel A. Rabinovich, William Vainchenker, Jean‐François Bach, Sophie Koutouzov, Anne Caignard, Christophe Borg and Abdelali Jalil and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Nature Immunology.

In The Last Decade

Diego J. Laderach

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego J. Laderach Argentina 20 1.1k 660 291 86 66 29 1.4k
Venkateswara R. Simhadri United States 18 1.1k 0.9× 412 0.6× 349 1.2× 116 1.3× 38 0.6× 21 1.4k
Ravi Hingorani United States 18 1.1k 1.0× 434 0.7× 268 0.9× 158 1.8× 84 1.3× 21 1.5k
Stefan Stevanović Germany 15 929 0.8× 596 0.9× 270 0.9× 128 1.5× 56 0.8× 27 1.3k
Xinhui Wang United States 17 652 0.6× 344 0.5× 318 1.1× 61 0.7× 27 0.4× 29 1.0k
Luis Soares United States 15 871 0.8× 533 0.8× 344 1.2× 115 1.3× 29 0.4× 25 1.3k
María T. Elola Argentina 19 1.1k 1.0× 940 1.4× 240 0.8× 36 0.4× 26 0.4× 29 1.5k
Woong‐Kyung Suh Canada 23 1.2k 1.1× 573 0.9× 505 1.7× 169 2.0× 44 0.7× 41 1.8k
John Copier United Kingdom 15 449 0.4× 379 0.6× 270 0.9× 129 1.5× 45 0.7× 29 902
Kent S. Boles United States 12 1.3k 1.1× 384 0.6× 453 1.6× 100 1.2× 26 0.4× 13 1.7k
Sébastien Storck France 16 650 0.6× 504 0.8× 125 0.4× 101 1.2× 34 0.5× 19 1.2k

Countries citing papers authored by Diego J. Laderach

Since Specialization
Citations

This map shows the geographic impact of Diego J. Laderach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego J. Laderach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego J. Laderach more than expected).

Fields of papers citing papers by Diego J. Laderach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego J. Laderach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego J. Laderach. The network helps show where Diego J. Laderach may publish in the future.

Co-authorship network of co-authors of Diego J. Laderach

This figure shows the co-authorship network connecting the top 25 collaborators of Diego J. Laderach. A scholar is included among the top collaborators of Diego J. Laderach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego J. Laderach. Diego J. Laderach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laderach, Diego J. & Daniel Compagno. (2023). Inhibition of galectins in cancer: Biological challenges for their clinical application. Frontiers in Immunology. 13. 1104625–1104625. 19 indexed citations
2.
Compagno, Daniel, et al.. (2020). Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials. Biomolecules. 10(5). 750–750. 43 indexed citations
3.
Compagno, Daniel, et al.. (2018). Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity. Frontiers in Immunology. 9. 2190–2190. 25 indexed citations
4.
Gentilini, Lucas D., Geraldine Gueron, Roberto P. Meiss, et al.. (2017). In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development. Clinical Cancer Research. 23(17). 5135–5148. 24 indexed citations
5.
Gentilini, Lucas D., et al.. (2017). Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer. Oncotarget. 8(27). 44654–44668. 40 indexed citations
6.
Chaves‐Ferreira, Miguel, Florence Vasseur, Pedro Gonçalves, et al.. (2016). The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells. Biology Direct. 11(1). 21–21. 6 indexed citations
7.
Cerliani, Juan P., Tomás Dalotto‐Moreno, Daniel Compagno, et al.. (2014). Study of Galectins in Tumor Immunity: Strategies and Methods. Methods in molecular biology. 1207. 249–268. 6 indexed citations
8.
Salatino, Mariana, Diego O. Croci, Diego J. Laderach, et al.. (2014). Regulation of Galectins by Hypoxia and Their Relevance in Angiogenesis: Strategies and Methods. Methods in molecular biology. 1207. 293–304. 3 indexed citations
9.
Compagno, Daniel, et al.. (2014). Glycans and galectins in prostate cancer biology, angiogenesis and metastasis. Glycobiology. 24(10). 899–906. 46 indexed citations
10.
Ferragut, Fátima, Lucas D. Gentilini, Diego J. Laderach, et al.. (2014). Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors.. PubMed. 29(9). 1093–105. 44 indexed citations
11.
Troncoso, María F., Fátima Ferragut, María L Bacigalupo, et al.. (2014). Galectin-8: A matricellular lectin with key roles in angiogenesis. Glycobiology. 24(10). 907–914. 62 indexed citations
12.
Compagno, Daniel, Lucas D. Gentilini, Ileana Montoya Perez, et al.. (2014). Galectins: Major Signaling Modulators Inside and Outside the Cell. Current Molecular Medicine. 14(5). 630–651. 49 indexed citations
13.
Laderach, Diego J., Lucas D. Gentilini, Diego O. Croci, et al.. (2012). A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease. Cancer Research. 73(1). 86–96. 138 indexed citations
14.
Laderach, Diego J., Daniel Compagno, Marta A. Toscano, et al.. (2009). Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings. IUBMB Life. 62(1). 1–13. 41 indexed citations
15.
Laderach, Diego J., Daniel Compagno, Olivier Danos, William Vainchenker, & Anne Galy. (2003). RNA Interference Shows Critical Requirement for NF-κB p50 in the Production of IL-12 by Human Dendritic Cells. The Journal of Immunology. 171(4). 1750–1757. 62 indexed citations
16.
Seifert, Ulrike, Concepción Marañón, Ayelet Shmueli, et al.. (2003). An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nature Immunology. 4(4). 375–379. 179 indexed citations
17.
Laderach, Diego J., Sophie Koutouzov, Jean‐François Bach, & Ana Maria Yamamoto. (2003). Concomitant early appearance of anti-ribonucleoprotein and anti-nucleosome antibodies in lupus prone mice. Journal of Autoimmunity. 20(2). 161–170. 20 indexed citations
18.
Laderach, Diego J., Mercedeh Movassagh, Arthur G. Johnson, Robert S. Mittler, & Anne Galy. (2002). 4-1BB co-stimulation enhances human CD8+ T cell priming by augmenting the proliferation and survival of effector CD8+ T cells. International Immunology. 14(10). 1155–1167. 85 indexed citations
19.
Laderach, Diego J., et al.. (1996). Trypanosoma cruzi: The major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII). International Journal for Parasitology. 26(11). 1249–1254. 19 indexed citations
20.
Cerbán, Fabio M., Claudia Cristina Motrán, Diego J. Laderach, et al.. (1994). Trypanosoma cruzi: Immunological cross-reactivity of the major cysteinyl proteinase (cruzipain) with a parasite cytosol acidic antigen (F IV). Acta Tropica. 58(3-4). 337–343. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venkateswara R. Simhadri Breakdown of academic impact, for papers by Ravi Hingorani Breakdown of academic impact, for papers by Stefan Stevanović Breakdown of academic impact, for papers by Xinhui Wang Breakdown of academic impact, for papers by Luis Soares Breakdown of academic impact, for papers by María T. Elola Breakdown of academic impact, for papers by Woong‐Kyung Suh Breakdown of academic impact, for papers by John Copier Breakdown of academic impact, for papers by Kent S. Boles Breakdown of academic impact, for papers by Sébastien Storck
Rankless by CCL
2026